ERG deletion is associated with CD2 and attenuates the negative impact of IKZF1 deletion in childhood acute lymphoblastic leukemia.

Zaliova, M; Zimmermannova, O; Dörge, P; Eckert, C; Möricke, A; Zimmermann, M; Stuchly, J; Teigler-Schlegel, A; Meissner, B; Koehler, R; Bartram, C R; Karawajew, L; Rhein, P; Zuna, J; Schrappe, M; Cario, G; Stanulla, M

Zaliova, M; Zimmermannova, O; Dörge, P; Eckert, C; Möricke, A; Zimmermann, M; Stuchly, J; Teigler-Schlegel, A; Meissner, B; Koehler, R; Bartram, C R; Karawajew, L; Rhein, P; Zuna, J; Schrappe, M; Cario, G; Stanulla, M.

Afiliação

Zaliova M; 1] Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany [2] CLIP-Childhood Leukemia Investigation Prague, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic [3] Pediatric Hemato
Zimmermannova O; CLIP-Childhood Leukemia Investigation Prague, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
Dörge P; Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.
Eckert C; Pediatric Hematology and Oncology, Charité University Hospital, Berlin, Germany.
Möricke A; Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.
Zimmermann M; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
Stuchly J; CLIP-Childhood Leukemia Investigation Prague, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
Teigler-Schlegel A; Oncogenetic laboratory, Pediatric Hematology and Oncology, University of Giessen, Giessen, Germany.
Meissner B; Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.
Koehler R; Department of Human Genetics, University of Heidelberg, Heidelberg, Germany.
Bartram CR; Department of Human Genetics, University of Heidelberg, Heidelberg, Germany.
Karawajew L; Pediatric Hematology and Oncology, Charité University Hospital, Berlin, Germany.
Rhein P; Pediatric Hematology and Oncology, Charité University Hospital, Berlin, Germany.
Zuna J; CLIP-Childhood Leukemia Investigation Prague, Department of Pediatric Hematology and Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic.
Schrappe M; Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.
Cario G; Department of Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany.
Stanulla M; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.

Leukemia ; 28(1): 182-5, 2014 Jan.

Article em En | MEDLINE | ID: mdl-24072102

Assuntos

Antígenos CD2/metabolismo; Fator de Transcrição Ikaros/genética; Leucemia-Linfoma Linfoblástico de Células Precursoras/genética; Transativadores/genética; Criança; Pré-Escolar; Feminino; Humanos; Lactente; Masculino; Transativadores/metabolismo; Regulador Transcricional ERG

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Leucemia Base de dados: MEDLINE Assunto principal: Transativadores / Antígenos CD2 / Fator de Transcrição Ikaros / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Risk_factors_studies Limite: Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Leukemia Assunto da revista: HEMATOLOGIA / NEOPLASIAS Ano de publicação: 2014 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google